Postbiotics as Adjuvant Therapy in Cancer Care
Nutrients · 2024
DOI: 10.3390/nu16152400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Vyshnavy Balendra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Saint James School of Medicine, Park Ridge, IL 60068, USA. Hauptthemen laut MEDLINE: Neoplasms, Probiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero Della Salute, Italian Ministry of Health.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Postbiotics are defined as a preparation of inanimate microorganisms and/or their components that confers a health benefit to the host. They range from cell wall fragments to metabolites, bacterial lysates, extracellular vesicles, and short-chain fatty acids (SCFAs). Postbiotics may influence carcinogenesis via a variety of mechanisms. They can promote homeostatic immune responses, reduce inflammation, induce selective cytotoxicity against tumor cells, as well as the enabling the control of tumor cell proliferation and enhancing intestinal epithelial barrier function. Therefore, probiotics can serve as an adjunct strategy in anticancer treatment together with chemotherapy and immunotherapy. Up to now, the only relevant postbiotics used as interventions in oncological patients remain vitamin K molecules, with few phase-II and III trials available. In fact, postbiotics’ levels are strictly dependent on the gut microbiota’s composition, which may vary between individuals and can be altered under different physiological and pathological conditions. Therefore, the lack of consistent clinical evidence supporting postbiotics’ efficacy is due to their poor bioavailability, short half-life, and fluctuating levels. Synbiotics, a mixture of prebiotics and probiotics, are expected to have a more homogeneous bioavailability with respect to postbiotics and may have greater potential for future development. In this review, we focus on the role of postbiotics as an adjuvant therapy in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Saint James School of Medicine, Park Ridge, IL 60068, USA.
- Oncology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- National Order of Biologist, 10122 Turin, Italy.
ORCID-Profile: Vyshnavy Balendra, Chiara Amoroso, Ornella Garrone, Michele Ghidini
Förderung
- Ministero Della Salute
- Italian Ministry of Health
Zitieren
APA
Balendra, V., Rosenfeld, R., Amoroso, C., Castagnone, C., Rossino, M. G., Garrone, O., & Ghidini, M. (2024). Postbiotics as Adjuvant Therapy in Cancer Care. Nutrients. https://doi.org/10.3390/nu16152400
Vancouver
Balendra V, Rosenfeld R, Amoroso C, Castagnone C, Rossino MG, Garrone O, et al. Postbiotics as Adjuvant Therapy in Cancer Care. Nutrients. 2024. doi:10.3390/nu16152400
BibTeX
@article{Balendra2024,
author = {Balendra, Vyshnavy and Rosenfeld, Roberto and Amoroso, Chiara and Castagnone, Cecilia and Rossino, Maria Grazia and Garrone, Ornella and Ghidini, Michele},
title = {Postbiotics as Adjuvant Therapy in Cancer Care},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16152400}
}
EUVIMED